317 related articles for article (PubMed ID: 25026005)
21. [Reduction of Treatment Duration in Periprosthetic Infection with a Fast-Track Concept Is Economically Not Feasible].
Lieb E; Hanstein T; Schuerings M; Trampuz A; Perka C
Z Orthop Unfall; 2015 Dec; 153(6):618-23. PubMed ID: 26468925
[TBL] [Abstract][Full Text] [Related]
22. [Economic aspects of inpatient treatment for decompensated liver cirrhosis: a prospective study employing an evidence-based clinical pathway].
Hahn N; Bobrowski C; Weber E; Simon P; Kraft M; Aghdassi A; Raetzell M; Wilke M; Lerch MM; Mayerle J
Z Gastroenterol; 2013 Mar; 51(3):278-86. PubMed ID: 23299901
[TBL] [Abstract][Full Text] [Related]
23. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
[TBL] [Abstract][Full Text] [Related]
24. [Elevated costs of treatment in medical inpatients with psychiatric comorbidity are not reflected in the German DRG-system].
Hochlehnert A; Niehoff D; Herzog W; Löwe B
Psychother Psychosom Med Psychol; 2007 Feb; 57(2):70-5. PubMed ID: 17211776
[TBL] [Abstract][Full Text] [Related]
25. Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014.
Bähler C; Vavricka SR; Schoepfer AM; Brüngger B; Reich O
BMC Gastroenterol; 2017 Dec; 17(1):138. PubMed ID: 29197335
[TBL] [Abstract][Full Text] [Related]
26. Descriptive epidemiology of children hospitalized for inflammatory bowel disease in Japan: Inpatient database analysis.
Takeuchi M; Tomomasa T; Yasunaga H; Horiguchi H; Fushimi K
Pediatr Int; 2015 Jun; 57(3):443-8. PubMed ID: 25442802
[TBL] [Abstract][Full Text] [Related]
27. [Cost of early management of chronic inflammatory intestinal disease].
Rolland N; Grandbastien B; Merle V; Gower-Rousseau C; Yzet T; Marti R; Lerebours E; Dupas JL; Czernichow P; Salomez JL; Lebrun T; Cortot A
Gastroenterol Clin Biol; 1999 Apr; 23(4):483-8. PubMed ID: 10416112
[TBL] [Abstract][Full Text] [Related]
28. [Cost measurement based on a cost diary in patients with inflammatory bowel disease].
Rösch M; Leidl R; Tirpitz Cv; Reinshagen M; Adler G; König HH
Z Gastroenterol; 2002 Apr; 40(4):217-28. PubMed ID: 11961730
[TBL] [Abstract][Full Text] [Related]
29. Mental Health Costs of Inflammatory Bowel Diseases.
Szigethy E; Murphy SM; Ehrlich OG; Engel-Nitz NM; Heller CA; Henrichsen K; Lawton R; Meadows P; Allen JI
Inflamm Bowel Dis; 2021 Jan; 27(1):40-48. PubMed ID: 32095835
[TBL] [Abstract][Full Text] [Related]
30. The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel Disease.
Targownik LE; Benchimol EI; Witt J; Bernstein CN; Singh H; Lix L; Tennakoon A; Zubieta AA; Coward S; Jones J; Kuenzig E; Murthy SK; Nguyen GC; Peña-Sánchez JN; Kaplan G
Inflamm Bowel Dis; 2019 Sep; 25(10):1718-1728. PubMed ID: 31211836
[TBL] [Abstract][Full Text] [Related]
31. [Cost analysis of contrast-enhanced cranial MRI at a German university hospital].
Schreyer AG; Friedrich C; Mrosek S; Hoffstetter P; Rennert J; Framme C; Jung EM; Feuerbach S; Schöffski O; Zorger N
Rofo; 2010 Oct; 182(10):891-9. PubMed ID: 20563960
[TBL] [Abstract][Full Text] [Related]
32. High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study.
Murthy SK; James PD; Antonova L; Chalifoux M; Tanuseputro P
PLoS One; 2017; 12(5):e0177211. PubMed ID: 28498877
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with readmissions and outcomes of patients hospitalized for inflammatory bowel disease.
Nguyen GC; Bollegala N; Chong CA
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1897-1904.e1. PubMed ID: 24681074
[TBL] [Abstract][Full Text] [Related]
34. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory bowel diseases increase future ischemic stroke risk: a Taiwanese population-based retrospective cohort study.
Huang WS; Tseng CH; Chen PC; Tsai CH; Lin CL; Sung FC; Kao CH
Eur J Intern Med; 2014 Jul; 25(6):561-5. PubMed ID: 24906568
[TBL] [Abstract][Full Text] [Related]
36. Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital.
Ebinger M; Leidl R; Thomas S; Von Tirpitz C; Reinshagen M; Adler G; Konig HH
J Gastroenterol Hepatol; 2004 Feb; 19(2):192-9. PubMed ID: 14731130
[TBL] [Abstract][Full Text] [Related]
37. Comparison of actual hospital costs versus DRG revenues for in-patient treatment of febrile neutropenia during adjuvant anthracycline plus/minus taxane-based chemotherapy for primary breast cancer.
Jacobs VR; Mayer SC; Paessens BJ; Bernard R; Harbeck N; Kiechle M; Ihbe-Heffinger A
Onkologie; 2011; 34(11):614-8. PubMed ID: 22104158
[TBL] [Abstract][Full Text] [Related]
38. Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases.
Limsrivilai J; Stidham RW; Govani SM; Waljee AK; Huang W; Higgins PD
Clin Gastroenterol Hepatol; 2017 Mar; 15(3):385-392.e2. PubMed ID: 27645518
[TBL] [Abstract][Full Text] [Related]
39. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
Wolfenstetter SB
Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
[TBL] [Abstract][Full Text] [Related]
40. Malnutrition and its impact on cost of hospitalization, length of stay, readmission and 3-year mortality.
Lim SL; Ong KC; Chan YH; Loke WC; Ferguson M; Daniels L
Clin Nutr; 2012 Jun; 31(3):345-50. PubMed ID: 22122869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
